Lateral Canthal Lines
📧 Sign up to get email alerts when something new happens for Lateral Canthal Lines.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines [Phase 3]
Phase 3 clinical trial evaluating QM1114-DP for aesthetic improvement in moderate to severe glabellar frown lines and lateral canthal lines …
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: MT10109L in the Treatment of Lateral Canthal Lines [Phase 3]
Phase 3 trial update for MT10109L in treating lateral canthal lines has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination [Phase 3]
Phase 3 clinical trial update for treatment of moderate to severe lateral canthal lines and glabellar lines, alone or in combination, comple…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines [Phase 3]
A Phase 3 clinical trial evaluating MT10109L for treating lateral canthal lines, with or without concurrent glabellar line treatment, has co…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines [Phase 2]
Phase 2 clinical trial results for DaxibotulinumtoxinA (DAXI) for injection show efficacy and safety in treating upper facial lines (glabell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines [Phase 2]
Phase 2 trial evaluating increasing doses of DaxibotulinumtoxinA for Injection (DAXI) for moderate to severe lateral canthal lines; results …
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Treatment of Moderate to Severe Lateral Canthal Lines [Phase 3]
Phase 3 trial completed for treatment of moderate to severe lateral canthal lines; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines [Phase 3]
Phase 3 trial update for long-term treatment of glabellar lines and lateral canthal lines shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL) [Phase 3]
Phase 3 trial evaluating MT10109L for glabellar lines with or without concurrent treatment of lateral canthal lines has completed and result…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: ET-01 in Subjects With Lateral Canthal Lines, LCL-208 [Phase 2]
Phase 2 trial update for ET-01 in adults with lateral canthal lines (crow's feet) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: ET-01 in Subjects With Lateral Canthal Lines, LCL-209 [Phase 2]
Phase 2 clinical trial update for ET-01 in subjects with lateral canthal lines (crow's feet) has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: ET-01 in Subjects With Lateral Canthal Lines, LCL-207 [Phase 2]
Phase 2 clinical trial update for ET-01 in adults with lateral canthal lines (crow's feet) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: ET-01 in Subjects With Lateral Canthal Lines [Phase 2]
Phase 2 clinical trial update for ET-01 in subjects with lateral canthal lines (crow's feet) with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines [Phase 2]
Phase 2 trial evaluating the efficacy and safety of MBA-P01 for treatment of lateral canthal lines has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines [Phase 2]
Phase 2 clinical trial assessing RT001 for safety and efficacy in treating moderate to severe lateral canthal lines has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults [Phase 2]
A Phase 2 clinical trial evaluating RT001 for efficacy and safety in adults with moderate to severe lateral canthal lines (crow's feet/facia…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet) [Phase 2]
Phase 2 clinical trial update evaluating Botulinum Type A toxin for treating crow's feet (lateral canthal lines) is completed.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: BOTOX® in the Treatment of Crow's Feet Lines in China [Phase 3]
Phase 3 study of BOTOX (onabotulinumtoxinA) for crow's feet lines and lateral canthal lines in China has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines [Phase 2]
Phase 2 safety and efficacy results for RT001 in treating moderate-to-severe lateral canthal lines are reported, with the study completed. T…